Aspire Biopharma Has Entered Into a Letter of Intent to Acquire a Leading Global Automotive Supplier With a 100+ Year History and $200M+ in 2025 Revenue

ESTERO, FL / ACCESS Newswire / April 16, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a biopharmaceutical company developing multi-faceted patent-pending drug ...

Aspire Biopharma Announces Milestone Roadmap Targeting H2 2025 FDA Submission for Sublingual Aspirin and Key 2026 Milestones for Needle-Free Semagl…

Prioritizes High-Value Approved Drugs in Multi-Billion-Dollar Markets to Accelerate Commercialization Future Platform ...

Aspire Biopharma Holdings, Inc.

View Aspire Biopharma Holdings, Inc. ASBP stock quote prices, financial information, real-time forecasts, and company news from CNN.
Visual Studio Magazine

.NET Aspire 9.5 Simplifies AppHost, Expands AI Support

Microsoft announced the release of .NET Aspire 9.5, the latest update to its opinionated stack for building distributed cloud-native applications with .NET. The new version introduces improvements ...